Unlike the HM2, TORVAD caused minimal VWF degradation and hemolysis and did not activate platelets in an ex vivo study, and sheep implanted with TORVAD showed similar findings with no thromboembolism despite lack of anticoagulation [162,163]. The gene discussed is VWF; the disease is Thromboembolism.